enGene Therapeutics Inc. (ENGN) Insider Trading

Name: enGene Therapeutics Inc. (ENGN) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 24, 2026): William Grossman (Interim Chief Medical Officer): Purchase of 5,102 shares, $10.1K.

Get alerted when insiders trade ENGN

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta